Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence-Reference-Cited by-同舟云学术

Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence

Published:2022-05 Issue: Volume:116 Page:106756
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Johnson Stuart,Gerding Dale N.,Li Xue,Reda Domenic J.,Donskey Curtis J.,Gupta Kalpana,Goetz Matthew Bidwell,Climo Michael W.,Gordin Fred M.,Ringer Robert,Johnson Neil,Johnson Michelle,Calais Lawrence A.,Goldberg Alexa M.,Ge Ling,Haegerich Tamara

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference28 articles.

1. Bezlotoxumab for prevention of recurrent Clostridium difficile infection;Wilcox;N. Engl. J. Med.,2017

2. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on Management of clostridioides difficile infection in adults;Johnson;Clin. Infect. Dis.,2021

3. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA);McDonald;Clin. Infect. Dis.,2018

4. ACG clinical guidelines: prevention, diagnosis, and treatment of clostridioides difficile infections;Kelly;Am. J. Gastroenterol.,2021

5. High Horn’s index score predicts poor outcomes in patients with Clostridium difficile infection;Arora;J. Hosp. Infect.,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutics involved in managing initial and recurrent Clostridium difficile infection: An updated literature review;World Journal of Gastrointestinal Pharmacology and Therapeutics;2024-09-05

2. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options;Clinical Microbiology Reviews;2024-06-13

3. Microbiome-preserving antibiotics for the treatment of Clostridioides difficile infection: a systematic review and meta-analysis;Techniques in Coloproctology;2023-12-19

4. Fidaxomicin for the Treatment of Clostridioides difficile Infection in Adult Patients: An Update on Results from Randomized Controlled Trials;Antibiotics;2022-10-06